AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.240
-0.030 (-0.92%)
Nov 20, 2024, 4:00 PM EST - Market closed
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 270.37% from the current stock price of 3.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +393.83% | Nov 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +393.83% | Nov 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +393.83% | Sep 18, 2024 |
BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +146.91% | May 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +393.83% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
6.88M
from 14.80M
Decreased by -53.52%
Revenue Next Year
71.45M
from 6.88M
Increased by 938.44%
EPS This Year
-0.61
from -0.64
EPS Next Year
-0.17
from -0.61
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 13.3M | 147.8M | 178.8M | ||
Avg | 6.9M | 71.4M | 68.7M | ||
Low | 1.7M | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -10.1% | 2,048.5% | 150.2% | ||
Avg | -53.5% | 938.4% | -3.9% | ||
Low | -88.4% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.54 | 0.37 | 0.68 | ||
Avg | -0.61 | -0.17 | -0.42 | ||
Low | -0.78 | -0.75 | -0.88 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.